We are proud to announce the expansion of our partnership with iFAST Diagnostics as its first commercial laboratory partner in the UK. Following validation earlier this year, our work with iFAST will focus on integrating rapid antimicrobial susceptibility testing (AST) into our laboratory workflows, and on developing the evidence healthcare organisations and NHS decision-makers need [...]
SYNLAB UK & Ireland is delighted to announce the appointment of Dr John Burke as Chief Medical Officer. This appointment is pivotal to the advancement of our clinical strategy as SYNLAB remains at the forefront of advancing diagnostics in the UK. John joins SYNLAB from AXA where he served as Chief Medical Officer from 2023. […]
Introduction This Modern Slavery and Human Trafficking Statement sets out the actions taken by SYNLAB UK & Ireland to identify, prevent, and address risks of modern slavery within our operations and supply chains during the 2025 financial year. Our Organisational Structure, Business Model & Supply Chain SYNLAB Group offer services in more than 20 countries [...]
INTRODUCTION This is SYNLAB UK & Ireland’s Modern Slavery and Human Trafficking Statement under Section 54 of the UK Modern Slavery Act 2015 for the financial year 2024. Modern slavery is a broad term that encompasses slavery, servitude, forced and compulsory labour and human trafficking. SYNLAB UK and Ireland is part of SYNLAB Group which [...]
